JPRN-jRCTs052220145招募中4 期
Prasugrel Monotherapy Following PrImary Percutaneous Coronary Interventionfor ST-elevation Myocardial Infarction - PREMIUM
akazawa Gaku0 个研究点目标入组 2,258 人开始时间: 2023年1月5日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 2,258
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients scheduled for Primary PCI with everolimus-eluting stent (PtCr-EES, SYNERGY)
- •STEMI patients
- •Patients who can continue dual antiplatelet therapy with aspirin and a P2Y12 inhibitor for 12 months
排除标准
- •Patients taking anticoagulants
- •Under 18 years old
- •Prognosis less than 1 year
- •Participated in other intervention studies
研究者
相似试验
招募中
4 期
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial InfarctionST-segment Elevation Myocardial Infarction (STEMI)NCT05709626Kindai University2,258
进行中（未招募）
不适用
A comparison of prasugrel at the time of percutaneous coronary intervention (PCI) or as pretreatment at the time of diagnosis in patients with NOn-ST-elevation myocardial infarction(NSTEMI): the ACCOAST study - ACCOAST StudyMedDRA version: 9.1Level: LLTClassification code 10051592Acute Coronary SyndromeEUCTR2009-014176-22-ITEli Lilly & Company4,100
进行中（未招募）
不适用
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI): The ACCOAST Study - ACCOASTAcute Coronary SyndromesMedDRA version: 14.1Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disordersEUCTR2009-014176-22-PLEli Lilly and Company4,100
进行中（未招募）
不适用
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADFAcute Coronary SyndromesMedDRA version: 12.0Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2009-014176-22-HUEli Lilly4,100
进行中（未招募）
1 期
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADFAcute Coronary SyndromesMedDRA version: 13.1Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disordersEUCTR2009-014176-22-BEEli Lilly4,100